Precision medicine: lessons learned from the SHIVA trial - Authors' reply

Lancet Oncol. 2015 Dec;16(16):e581-2. doi: 10.1016/S1470-2045(15)00455-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / genetics*
  • Female
  • Gene Expression Profiling*
  • Humans
  • Male
  • Molecular Diagnostic Techniques*
  • Molecular Targeted Therapy*
  • Neoplasms / drug therapy*
  • Precision Medicine*

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor